One Pharma Drugs & Pharmaceuticals Private Limited
Levosulpiride (75mg) + Esomeprazole (40mg)
Somone L 75mg/40mg Capsule is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux) by relieving symptoms such as heartburn, stomach pain, or irritation.
Capsule
Somone L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole. It works by relieving the symptoms of gastroesophageal reflux disease (acid reflux) and neutralizing the acid production in the stomach to prevent discomfort.
Take this medicine in the dose and duration as advised by your doctor. Somone L 75mg/40mg Capsule is to be taken empty stomach.
Somone L 75mg/40mg Capsule is a combination of two medicines: Levosulpiride and Esomeprazole.
Do not consume alcohol while taking Somone L 75mg/40mg Capsule as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Somone L 75mg/40mg Capsule for longer than prescribed.
Store Somone L 75mg/40mg Capsule in its original container, tightly closed. Follow the packaging directions or label instructions for storage. Dispose of unused medication appropriately. Ensure that pets, children, and other individuals do not have access to this medicine.
Take Somone L 75mg/40mg Capsule exactly as prescribed by your healthcare professional. It's generally recommended to swallow one capsule on an empty stomach.
Patients who are allergic to any component or excipient in Somone L 75mg/40mg Capsule should avoid using this medication. It's crucial to consult your doctor if you have any allergies before starting this medication.
Yes, Somone L 75mg/40mg Capsule may cause dizziness (feeling faint, weak, unsteady or lightheaded) in some patients. If you experience dizziness or lightheadedness, it is advisable to rest and resume the medication when feeling better.
Studies suggest that long-term treatment with Somone L 75mg/40mg Capsule may increase the risk of osteoporosis-related fractures, particularly in the hip, wrist, and spine. It's important to note that this risk is associated with high doses and prolonged therapy (lasting a year or longer).